New Type of ‘Beta Blocker’ Drug Approved to Treat High Blood Pressure
FDA has approved Bystolic (nebivolol) for the treatment of high blood pressure. Bystolic is a “beta blocker,“ a well-established class of medications that reduces blood pressure by reducing the force with which the heart pumps. Nearly one in three adults in the United States has high blood pressure, also called hypertension, which can increase the risks for stroke, heart failure, heart attack, kidney failure, and death.
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01757.html
